Retinol oxidized to retinal (visual pigment 11-cis-retinal in rhodopsin) and to retinoic acid (gene-regulatory ligand)
Retinoic acid binds nuclear retinoic acid receptors (RAR-alpha/beta/gamma) and retinoid X receptors (RXR), regulating ~500 target genes including those for cell differentiation, immune function, and epithelial integrity
Maintains mucosal barrier integrity in respiratory, gastrointestinal, and urogenital epithelia via mucin synthesis and goblet cell differentiation
Required for normal photoreceptor function (rod and cone visual cycle) and dark adaptation
Modulates innate and adaptive immune responses including T-cell differentiation, dendritic cell function, and IgA production
Molecular + tissue targets
Visual cycle (rod/cone photoreceptors)
Epithelial mucosal barriers (respiratory / GI / urogenital)
Iron metabolism (mobilization from hepatic stores)
Dosage range
US IOM RDA: 900 mcg RAE/day adult men, 700 mcg RAE/day adult women (1300 mcg/day lactation). EFSA NDA PRI: 750 mcg RE/day adult men, 650 mcg RE/day adult women (700 mcg/day pregnancy, 1300 mcg/day lactation). EFSA NRV (labelling): 800 mcg RE. US IOM Tolerable Upper Intake Level (UL): 3000 mcg RAE/day adults (preformed retinol only; not applicable to provitamin A carotenoids). Common supplemental doses: 700-1500 mcg RAE/day. WHO high-dose supplementation programs use 100,000-200,000 IU intermittently in deficient children.
Safety notes
Pre-formed vitamin A (retinol / retinyl esters) is TERATOGENIC at high doses. Pregnancy supplementation >10,000 IU/day (>3000 mcg RAE/day) is associated with increased risk of birth defects (Rothman 1995 NEJM) and is contraindicated. UL of 3000 mcg RAE/day applies only to pre-formed vitamin A, not to provitamin A carotenoids (β-carotene). However, high-dose β-carotene supplementation (20-30 mg/day) in current and former heavy smokers was associated with INCREASED lung cancer incidence in the ATBC (Heinonen 1994 NEJM) and CARET (Omenn 1996 NEJM) trials and is contraindicated in this population. Chronic intake of pre-formed retinol above the UL may cause hypervitaminosis A (hepatotoxicity, intracranial pressure, bone loss). Hypothyroidism, renal/hepatic impairment, and alcohol use disorder may increase susceptibility to toxicity. Provitamin A (β-carotene from food) does not cause hypervitaminosis A but can cause reversible carotenodermia. Pregnancy: do not exceed 700 mcg RAE/day from supplements unless clinically directed; rely on dietary β-carotene rather than supplemental retinol for additional intake.
Cross-market regulatory status
🇺🇸 FDA
United States (FDA): NO 21 CFR Part 101 Subpart E Significant Scientific Agreement (SSA) health claim exists for vitamin A. The SSA catalogue is limited to specific nutrient-disease pairs (calcium/osteoporosis, sodium/hypertension, dietary fat/cancer, saturated fat & cholesterol/CHD, fiber-grain products/cancer, fiber-fruits-vegetables/CHD, folate/NTDs, sugar alcohols/dental caries, soluble fiber/CHD, soy protein/CHD, plant sterol-stanol/CHD, fluoride/dental caries) — none of which involve vitamin A. Vitamin A in dietary supplements is governed by: (1) DSHEA §403(r)(6) structure/function claims under 21 CFR 101.93 with the mandatory disclaimer "This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease."; (2) nutrient-content claims under 21 CFR 101.54 (e.g., "high in", "good source of vitamin A"); (3) labeling per 21 CFR 101.9 with %DV based on the 900 mcg RAE adult reference. No FDA Qualified Health Claim (QHC) for vitamin A as a standalone nutrient has been issued at the standalone-nutrient level. Pre-formed vitamin A teratogenicity warning per FDA UL of 3,000 mcg RAE/day required on supplements; pregnancy supplementation >10,000 IU/day contraindicated.
🇪🇺 EFSA
European Union (EFSA / Reg 432/2012): Six authorized Article 13(1) general-function health claims for vitamin A in the Annex to Commission Regulation (EU) No 432/2012 (CELEX:32012R0432) — normal iron metabolism, maintenance of normal mucous membranes, maintenance of normal skin, maintenance of normal vision, normal function of the immune system, role in the process of cell specialisation. All six share the standard condition: claim may be used only for food which is at least a source of vitamin A per the SOURCE OF [VITAMIN/MINERAL] reference in the Annex to Regulation (EC) No 1924/2006 (>=15% NRV per 100 g/100 mL or per portion; NRV = 800 mcg RE per Regulation (EU) No 1169/2011 Annex XIII). Claims 1-5 use "contributes to" verb; claim 6 uses "has a role in" — character-level second-pass verified. EFSA NDA Panel underlying opinion: EFSA Journal 2009;7(9):1221. No Article 14 disease-risk-reduction claim authorised for vitamin A.
🇧🇷 ANVISA
Brasil (ANVISA): Vitamina A é constituinte autorizado para suplementos alimentares conforme Instrução Normativa DC/ANVISA nº 28, de 26/07/2018 (Anexos I/II — lista de constituintes; Anexos III/IV — limites mínimos e máximos calculados como equivalente de atividade de retinol, RAE; Anexo V — alegações autorizadas). As alegações de propriedade funcional para vitamina A seguem o padrão "A vitamina A auxilia ..." (verbo "auxilia", não "contribui para"). Verbatim character-for-character requer consulta direta ao PDF oficial do BVSMS — authorized_claims ANVISA deste card intencionalmente ausentes até confirmação manual via leitura do PDF oficial. NOTA DE SEGURANÇA: vitamina A pré-formada (retinol/ésteres de retinila) tem teratogenicidade em altas doses; UL adulto = 3.000 mcg RAE/dia; suplementação em gestantes >10.000 UI/dia contraindicada (advertência obrigatória conforme RDC 243/2018).
The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group(1994)N Engl J Med
The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers
SAFETY CONTEXT (not vitamin A efficacy): ATBC trial tested BETA-CAROTENE 20 mg/d (not retinol) in n=29,133 Finnish male smokers · INCREASED lung cancer incidence vs placebo · cited here as safety boundary for high-dose β-carotene supplementation in smokers · NOT a vitamin A efficacy anchor
Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease
SAFETY CONTEXT (not vitamin A efficacy): CARET trial tested BETA-CAROTENE 30 mg/d + retinol 25,000 IU/d in heavy smokers and asbestos workers · halted early · INCREASED lung cancer · cited here as safety boundary for supplementation in high-risk lung-cancer populations · NOT a vitamin A efficacy anchor
Impact of vitamin A supplementation on childhood mortality. A randomised controlled community trial
Indonesia cluster-RCT 450 villages n=25,939 preschool children · 200,000 IU vitamin A capsules reduced childhood mortality (deficiency-population setting)
Direct quotes from each jurisdiction's framework · never paraphrased · with framework reference and conditions of use.
🇪🇺 EFSA · 6 claims
Reg 432/2012
Vitamin A contributes to normal iron metabolism
Conditions: The claim may be used only for food which is at least a source of vitamin A as referred to in the claim SOURCE OF [NAME OF VITAMIN/S] AND/OR [NAME OF MINERAL/S] as listed in the Annex to Regulation (EC) No 1924/2006.
Reg 432/2012
Vitamin A contributes to the maintenance of normal mucous membranes
Conditions: The claim may be used only for food which is at least a source of vitamin A as referred to in the claim SOURCE OF [NAME OF VITAMIN/S] AND/OR [NAME OF MINERAL/S] as listed in the Annex to Regulation (EC) No 1924/2006.
Reg 432/2012
Vitamin A contributes to the maintenance of normal skin
Conditions: The claim may be used only for food which is at least a source of vitamin A as referred to in the claim SOURCE OF [NAME OF VITAMIN/S] AND/OR [NAME OF MINERAL/S] as listed in the Annex to Regulation (EC) No 1924/2006.
Reg 432/2012
Vitamin A contributes to the maintenance of normal vision
Conditions: The claim may be used only for food which is at least a source of vitamin A as referred to in the claim SOURCE OF [NAME OF VITAMIN/S] AND/OR [NAME OF MINERAL/S] as listed in the Annex to Regulation (EC) No 1924/2006.
Reg 432/2012
Vitamin A contributes to the normal function of the immune system
Conditions: The claim may be used only for food which is at least a source of vitamin A as referred to in the claim SOURCE OF [NAME OF VITAMIN/S] AND/OR [NAME OF MINERAL/S] as listed in the Annex to Regulation (EC) No 1924/2006.
Reg 432/2012
Vitamin A has a role in the process of cell specialisation
Conditions: The claim may be used only for food which is at least a source of vitamin A as referred to in the claim SOURCE OF [NAME OF VITAMIN/S] AND/OR [NAME OF MINERAL/S] as listed in the Annex to Regulation (EC) No 1924/2006.
Common use cases
Daily nutritional support for normal vision
Skin and mucous membrane maintenance support
Immune function support
Iron metabolism co-factor support
Specific use in vitamin A deficiency populations (clinically supervised) per WHO programs
